nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—melanoma	0.18	0.512	CbGaD
Dronedarone—ABCB1—melanoma	0.172	0.488	CbGaD
Dronedarone—ALB—Vemurafenib—melanoma	0.0755	0.332	CbGbCtD
Dronedarone—CYP3A4—Temozolomide—melanoma	0.0432	0.19	CbGbCtD
Dronedarone—CYP2D6—Vemurafenib—melanoma	0.0372	0.164	CbGbCtD
Dronedarone—ABCB1—Dactinomycin—melanoma	0.0263	0.115	CbGbCtD
Dronedarone—CYP3A4—Vemurafenib—melanoma	0.0237	0.104	CbGbCtD
Dronedarone—CACNA1S—pes—melanoma	0.0228	0.294	CbGeAlD
Dronedarone—ABCB1—Docetaxel—melanoma	0.0136	0.0596	CbGbCtD
Dronedarone—CYP3A4—Docetaxel—melanoma	0.00812	0.0357	CbGbCtD
Dronedarone—Pulmonary toxicity—Carmustine—melanoma	0.00771	0.0643	CcSEcCtD
Dronedarone—CACNA1D—ear—melanoma	0.00528	0.068	CbGeAlD
Dronedarone—CACNA1F—eye—melanoma	0.00469	0.0604	CbGeAlD
Dronedarone—CACNA1F—retina—melanoma	0.00465	0.0599	CbGeAlD
Dronedarone—HCN1—head—melanoma	0.00464	0.0597	CbGeAlD
Dronedarone—Pulmonary fibrosis—Bleomycin—melanoma	0.00456	0.038	CcSEcCtD
Dronedarone—Traumatic liver injury—Temozolomide—melanoma	0.00454	0.0378	CcSEcCtD
Dronedarone—Pulmonary fibrosis—Carmustine—melanoma	0.00398	0.0332	CcSEcCtD
Dronedarone—Pulmonary fibrosis—Temozolomide—melanoma	0.00384	0.0321	CcSEcCtD
Dronedarone—HCN4—head—melanoma	0.00351	0.0453	CbGeAlD
Dronedarone—Vasculitis—Vemurafenib—melanoma	0.00339	0.0283	CcSEcCtD
Dronedarone—Hypomagnesaemia—Bleomycin—melanoma	0.00315	0.0263	CcSEcCtD
Dronedarone—Atrial flutter—Docetaxel—melanoma	0.00296	0.0247	CcSEcCtD
Dronedarone—HCN3—head—melanoma	0.00284	0.0366	CbGeAlD
Dronedarone—Interstitial lung disease—Bleomycin—melanoma	0.00283	0.0236	CcSEcCtD
Dronedarone—CACNA1F—head—melanoma	0.00266	0.0343	CbGeAlD
Dronedarone—HCN2—head—melanoma	0.00266	0.0343	CbGeAlD
Dronedarone—Pulmonary fibrosis—Docetaxel—melanoma	0.00256	0.0213	CcSEcCtD
Dronedarone—Interstitial lung disease—Carmustine—melanoma	0.00247	0.0206	CcSEcCtD
Dronedarone—Interstitial lung disease—Temozolomide—melanoma	0.00239	0.0199	CcSEcCtD
Dronedarone—Liver injury—Temozolomide—melanoma	0.00201	0.0168	CcSEcCtD
Dronedarone—Photosensitivity reaction—Vemurafenib—melanoma	0.00189	0.0158	CcSEcCtD
Dronedarone—CACNB3—mammalian vulva—melanoma	0.00187	0.0242	CbGeAlD
Dronedarone—CACNB4—head—melanoma	0.00175	0.0226	CbGeAlD
Dronedarone—Interstitial lung disease—Docetaxel—melanoma	0.00159	0.0132	CcSEcCtD
Dronedarone—CACNB2—retina—melanoma	0.00157	0.0203	CbGeAlD
Dronedarone—Cardiac disorder—Vemurafenib—melanoma	0.00154	0.0129	CcSEcCtD
Dronedarone—Dermatitis atopic—Docetaxel—melanoma	0.00152	0.0127	CcSEcCtD
Dronedarone—Angiopathy—Vemurafenib—melanoma	0.00151	0.0126	CcSEcCtD
Dronedarone—Mediastinal disorder—Vemurafenib—melanoma	0.0015	0.0125	CcSEcCtD
Dronedarone—Rash erythematous—Docetaxel—melanoma	0.00147	0.0122	CcSEcCtD
Dronedarone—Erythema—Vemurafenib—melanoma	0.00145	0.0121	CcSEcCtD
Dronedarone—Dysgeusia—Vemurafenib—melanoma	0.00142	0.0118	CcSEcCtD
Dronedarone—CACNB1—head—melanoma	0.0014	0.018	CbGeAlD
Dronedarone—Ageusia—Docetaxel—melanoma	0.00139	0.0116	CcSEcCtD
Dronedarone—CACNB3—head—melanoma	0.00134	0.0173	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00122	0.0102	CcSEcCtD
Dronedarone—Anaphylactic shock—Vemurafenib—melanoma	0.00118	0.00984	CcSEcCtD
Dronedarone—Nervous system disorder—Vemurafenib—melanoma	0.00116	0.00965	CcSEcCtD
Dronedarone—Hypokalaemia—Carmustine—melanoma	0.00116	0.00964	CcSEcCtD
Dronedarone—Skin disorder—Vemurafenib—melanoma	0.00115	0.00956	CcSEcCtD
Dronedarone—Pneumonia—Bleomycin—melanoma	0.00113	0.0094	CcSEcCtD
Dronedarone—Hypokalaemia—Temozolomide—melanoma	0.00112	0.00931	CcSEcCtD
Dronedarone—KCNK2—lymph node—melanoma	0.00109	0.014	CbGeAlD
Dronedarone—Pneumonia—Dactinomycin—melanoma	0.00105	0.00877	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00102	0.0085	CcSEcCtD
Dronedarone—Fatigue—Vemurafenib—melanoma	0.00102	0.00849	CcSEcCtD
Dronedarone—Pneumonia—Carmustine—melanoma	0.000984	0.00821	CcSEcCtD
Dronedarone—CACNB1—lymph node—melanoma	0.000979	0.0126	CbGeAlD
Dronedarone—Photosensitivity reaction—Temozolomide—melanoma	0.000968	0.00807	CcSEcCtD
Dronedarone—Pneumonia—Temozolomide—melanoma	0.000951	0.00793	CcSEcCtD
Dronedarone—CACNB3—lymph node—melanoma	0.000939	0.0121	CbGeAlD
Dronedarone—CACNB2—head—melanoma	0.000901	0.0116	CbGeAlD
Dronedarone—Cardiac failure congestive—Docetaxel—melanoma	0.0009	0.0075	CcSEcCtD
Dronedarone—Hepatobiliary disease—Temozolomide—melanoma	0.000894	0.00746	CcSEcCtD
Dronedarone—Erythema—Bleomycin—melanoma	0.000876	0.00731	CcSEcCtD
Dronedarone—SCN1A—head—melanoma	0.000876	0.0113	CbGeAlD
Dronedarone—Asthenia—Vemurafenib—melanoma	0.000847	0.00706	CcSEcCtD
Dronedarone—Cardiac failure—Docetaxel—melanoma	0.000836	0.00697	CcSEcCtD
Dronedarone—Pruritus—Vemurafenib—melanoma	0.000835	0.00696	CcSEcCtD
Dronedarone—Erythema—Dactinomycin—melanoma	0.000817	0.00681	CcSEcCtD
Dronedarone—Diarrhoea—Vemurafenib—melanoma	0.000807	0.00673	CcSEcCtD
Dronedarone—ADRA1B—head—melanoma	0.000799	0.0103	CbGeAlD
Dronedarone—Cardiac disorder—Temozolomide—melanoma	0.000788	0.00657	CcSEcCtD
Dronedarone—CACNA1D—head—melanoma	0.000788	0.0101	CbGeAlD
Dronedarone—ADRA1D—head—melanoma	0.000781	0.0101	CbGeAlD
Dronedarone—Angiopathy—Temozolomide—melanoma	0.00077	0.00642	CcSEcCtD
Dronedarone—Immune system disorder—Temozolomide—melanoma	0.000767	0.00639	CcSEcCtD
Dronedarone—Mediastinal disorder—Temozolomide—melanoma	0.000765	0.00638	CcSEcCtD
Dronedarone—Erythema—Carmustine—melanoma	0.000765	0.00638	CcSEcCtD
Dronedarone—Vomiting—Vemurafenib—melanoma	0.00075	0.00626	CcSEcCtD
Dronedarone—Rash—Vemurafenib—melanoma	0.000744	0.00621	CcSEcCtD
Dronedarone—Dermatitis—Vemurafenib—melanoma	0.000743	0.0062	CcSEcCtD
Dronedarone—Erythema—Temozolomide—melanoma	0.000739	0.00616	CcSEcCtD
Dronedarone—CACNA1C—head—melanoma	0.000727	0.00937	CbGeAlD
Dronedarone—Dysgeusia—Temozolomide—melanoma	0.000724	0.00604	CcSEcCtD
Dronedarone—Anaphylactic shock—Bleomycin—melanoma	0.000715	0.00596	CcSEcCtD
Dronedarone—Nausea—Vemurafenib—melanoma	0.000701	0.00585	CcSEcCtD
Dronedarone—Angioedema—Temozolomide—melanoma	0.000675	0.00563	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—melanoma	0.000633	0.00528	CcSEcCtD
Dronedarone—CACNB2—lymph node—melanoma	0.000631	0.00813	CbGeAlD
Dronedarone—ABCB1—blood vessel—melanoma	0.000629	0.0081	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000625	0.00521	CcSEcCtD
Dronedarone—Anaphylactic shock—Temozolomide—melanoma	0.000603	0.00503	CcSEcCtD
Dronedarone—ADRA2C—mammalian vulva—melanoma	0.000598	0.0077	CbGeAlD
Dronedarone—Hepatobiliary disease—Docetaxel—melanoma	0.000595	0.00496	CcSEcCtD
Dronedarone—Nervous system disorder—Temozolomide—melanoma	0.000592	0.00493	CcSEcCtD
Dronedarone—Skin disorder—Temozolomide—melanoma	0.000586	0.00489	CcSEcCtD
Dronedarone—Fatigue—Dactinomycin—melanoma	0.000575	0.00479	CcSEcCtD
Dronedarone—ADRB1—head—melanoma	0.000567	0.00731	CbGeAlD
Dronedarone—CACNA1D—lymph node—melanoma	0.000552	0.00711	CbGeAlD
Dronedarone—Gastrointestinal pain—Dactinomycin—melanoma	0.000545	0.00455	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Carmustine—melanoma	0.000539	0.00449	CcSEcCtD
Dronedarone—Dyspepsia—Temozolomide—melanoma	0.000531	0.00443	CcSEcCtD
Dronedarone—Abdominal pain—Dactinomycin—melanoma	0.000527	0.0044	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—melanoma	0.000524	0.00437	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Temozolomide—melanoma	0.000521	0.00434	CcSEcCtD
Dronedarone—Fatigue—Temozolomide—melanoma	0.00052	0.00434	CcSEcCtD
Dronedarone—Asthenia—Bleomycin—melanoma	0.000513	0.00428	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—melanoma	0.000512	0.00427	CcSEcCtD
Dronedarone—Gastrointestinal pain—Carmustine—melanoma	0.00051	0.00426	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—melanoma	0.00051	0.00425	CcSEcCtD
Dronedarone—CACNA1C—lymph node—melanoma	0.000509	0.00656	CbGeAlD
Dronedarone—Mediastinal disorder—Docetaxel—melanoma	0.000509	0.00424	CcSEcCtD
Dronedarone—Pruritus—Bleomycin—melanoma	0.000506	0.00422	CcSEcCtD
Dronedarone—Abdominal pain—Carmustine—melanoma	0.000493	0.00411	CcSEcCtD
Dronedarone—Gastrointestinal pain—Temozolomide—melanoma	0.000493	0.00411	CcSEcCtD
Dronedarone—Erythema—Docetaxel—melanoma	0.000491	0.0041	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—melanoma	0.000481	0.00401	CcSEcCtD
Dronedarone—Asthenia—Dactinomycin—melanoma	0.000478	0.00399	CcSEcCtD
Dronedarone—Abdominal pain—Temozolomide—melanoma	0.000477	0.00398	CcSEcCtD
Dronedarone—ADRA2A—mammalian vulva—melanoma	0.000477	0.00614	CbGeAlD
Dronedarone—Diarrhoea—Dactinomycin—melanoma	0.000456	0.00381	CcSEcCtD
Dronedarone—Vomiting—Bleomycin—melanoma	0.000455	0.00379	CcSEcCtD
Dronedarone—Rash—Bleomycin—melanoma	0.000451	0.00376	CcSEcCtD
Dronedarone—Dermatitis—Bleomycin—melanoma	0.00045	0.00376	CcSEcCtD
Dronedarone—ADRA1A—head—melanoma	0.000449	0.00578	CbGeAlD
Dronedarone—Asthenia—Carmustine—melanoma	0.000448	0.00373	CcSEcCtD
Dronedarone—KCNH2—head—melanoma	0.000433	0.00558	CbGeAlD
Dronedarone—Asthenia—Temozolomide—melanoma	0.000433	0.00361	CcSEcCtD
Dronedarone—ADRA2C—head—melanoma	0.000428	0.00551	CbGeAlD
Dronedarone—Diarrhoea—Carmustine—melanoma	0.000427	0.00356	CcSEcCtD
Dronedarone—Pruritus—Temozolomide—melanoma	0.000427	0.00356	CcSEcCtD
Dronedarone—Nausea—Bleomycin—melanoma	0.000425	0.00354	CcSEcCtD
Dronedarone—Vomiting—Dactinomycin—melanoma	0.000424	0.00354	CcSEcCtD
Dronedarone—Rash—Dactinomycin—melanoma	0.00042	0.00351	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000416	0.00347	CcSEcCtD
Dronedarone—Diarrhoea—Temozolomide—melanoma	0.000413	0.00344	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—melanoma	0.000401	0.00335	CcSEcCtD
Dronedarone—Vomiting—Carmustine—melanoma	0.000397	0.00331	CcSEcCtD
Dronedarone—Nausea—Dactinomycin—melanoma	0.000396	0.0033	CcSEcCtD
Dronedarone—ALB—lymph node—melanoma	0.000395	0.00509	CbGeAlD
Dronedarone—Rash—Carmustine—melanoma	0.000394	0.00328	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—melanoma	0.000393	0.00328	CcSEcCtD
Dronedarone—Dermatitis—Carmustine—melanoma	0.000393	0.00328	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—melanoma	0.00039	0.00325	CcSEcCtD
Dronedarone—Vomiting—Temozolomide—melanoma	0.000383	0.0032	CcSEcCtD
Dronedarone—Rash—Temozolomide—melanoma	0.00038	0.00317	CcSEcCtD
Dronedarone—Dermatitis—Temozolomide—melanoma	0.00038	0.00317	CcSEcCtD
Dronedarone—Nausea—Carmustine—melanoma	0.000371	0.00309	CcSEcCtD
Dronedarone—Nausea—Temozolomide—melanoma	0.000358	0.00299	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—melanoma	0.000353	0.00294	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—melanoma	0.000346	0.00289	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—melanoma	0.000346	0.00288	CcSEcCtD
Dronedarone—ADRA2A—head—melanoma	0.000341	0.00439	CbGeAlD
Dronedarone—ABCB1—retina—melanoma	0.000332	0.00427	CbGeAlD
Dronedarone—Gastrointestinal pain—Docetaxel—melanoma	0.000328	0.00274	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—melanoma	0.000317	0.00264	CcSEcCtD
Dronedarone—KCNH2—lymph node—melanoma	0.000303	0.00391	CbGeAlD
Dronedarone—ADRA2C—lymph node—melanoma	0.000299	0.00386	CbGeAlD
Dronedarone—Asthenia—Docetaxel—melanoma	0.000288	0.0024	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—melanoma	0.000284	0.00237	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—melanoma	0.000274	0.00229	CcSEcCtD
Dronedarone—ABCB1—mammalian vulva—melanoma	0.000266	0.00342	CbGeAlD
Dronedarone—CYP2D6—head—melanoma	0.000264	0.0034	CbGeAlD
Dronedarone—Vomiting—Docetaxel—melanoma	0.000255	0.00213	CcSEcCtD
Dronedarone—Rash—Docetaxel—melanoma	0.000253	0.00211	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—melanoma	0.000253	0.00211	CcSEcCtD
Dronedarone—ADRA2A—lymph node—melanoma	0.000239	0.00308	CbGeAlD
Dronedarone—Nausea—Docetaxel—melanoma	0.000238	0.00199	CcSEcCtD
Dronedarone—ABCB1—head—melanoma	0.00019	0.00245	CbGeAlD
Dronedarone—ABCB1—lymph node—melanoma	0.000133	0.00171	CbGeAlD
Dronedarone—ADRA2C—Signaling Pathways—ERBB2—melanoma	4.31e-06	1.94e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MDM2—melanoma	4.3e-06	1.94e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAP2K1—melanoma	4.3e-06	1.93e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1B—melanoma	4.27e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—AKT1—melanoma	4.27e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CD—melanoma	4.27e-06	1.92e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—AKT1—melanoma	4.26e-06	1.92e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CG—melanoma	4.26e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CB—melanoma	4.25e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—AKT1—melanoma	4.25e-06	1.91e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—FASN—melanoma	4.25e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ERBB2—melanoma	4.24e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—BRAF—melanoma	4.24e-06	1.91e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—AKT1—melanoma	4.23e-06	1.9e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CASP3—melanoma	4.23e-06	1.9e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	4.23e-06	1.9e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—melanoma	4.22e-06	1.9e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—melanoma	4.2e-06	1.89e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—melanoma	4.19e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CB—melanoma	4.19e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—melanoma	4.18e-06	1.88e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC5A5—melanoma	4.18e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—melanoma	4.18e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—melanoma	4.16e-06	1.87e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CB—melanoma	4.13e-06	1.86e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—melanoma	4.13e-06	1.86e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—melanoma	4.12e-06	1.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK1—melanoma	4.11e-06	1.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—melanoma	4.11e-06	1.85e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—melanoma	4.11e-06	1.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—melanoma	4.09e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—melanoma	4.09e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FGF2—melanoma	4.09e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—melanoma	4.08e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CTNNB1—melanoma	4.08e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—melanoma	4.06e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CTNNB1—melanoma	4.04e-06	1.82e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GNAQ—melanoma	4.04e-06	1.82e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CD44—melanoma	4.04e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—melanoma	4.02e-06	1.81e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—melanoma	4.01e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—melanoma	4e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—melanoma	4e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1B—melanoma	3.99e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAP2K1—melanoma	3.99e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1A—melanoma	3.98e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—melanoma	3.97e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CD—melanoma	3.96e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—melanoma	3.96e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NFKB1—melanoma	3.95e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—melanoma	3.95e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1A—melanoma	3.94e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—melanoma	3.94e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—melanoma	3.94e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1B—melanoma	3.93e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	3.93e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NFKB1—melanoma	3.92e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—melanoma	3.91e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—melanoma	3.91e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—melanoma	3.9e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NRAS—melanoma	3.89e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—melanoma	3.89e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—melanoma	3.89e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—melanoma	3.88e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—melanoma	3.88e-06	1.74e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1B1—melanoma	3.87e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—melanoma	3.85e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—melanoma	3.85e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—melanoma	3.84e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	3.84e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—melanoma	3.83e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MDM2—melanoma	3.82e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—melanoma	3.81e-06	1.71e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FGF2—melanoma	3.8e-06	1.71e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CTNNB1—melanoma	3.77e-06	1.7e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—melanoma	3.77e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—melanoma	3.75e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CD—melanoma	3.74e-06	1.68e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—melanoma	3.73e-06	1.68e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—melanoma	3.72e-06	1.68e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CB—melanoma	3.72e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CTNNB1—melanoma	3.71e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—melanoma	3.7e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1A—melanoma	3.68e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—melanoma	3.68e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NFKB1—melanoma	3.66e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—melanoma	3.64e-06	1.64e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1A—melanoma	3.63e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—melanoma	3.62e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—melanoma	3.62e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NFKB1—melanoma	3.6e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—melanoma	3.6e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—melanoma	3.59e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—melanoma	3.59e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—melanoma	3.57e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—melanoma	3.57e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	3.57e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—melanoma	3.55e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—melanoma	3.55e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MDM2—melanoma	3.55e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—melanoma	3.55e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK1—melanoma	3.54e-06	1.59e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NRAS—melanoma	3.54e-06	1.59e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—melanoma	3.54e-06	1.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—melanoma	3.53e-06	1.59e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—melanoma	3.52e-06	1.58e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—melanoma	3.51e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NRAS—melanoma	3.51e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—melanoma	3.5e-06	1.57e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1B—melanoma	3.49e-06	1.57e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CB—melanoma	3.46e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—melanoma	3.45e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—melanoma	3.42e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—melanoma	3.42e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—melanoma	3.4e-06	1.53e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—melanoma	3.39e-06	1.53e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—melanoma	3.39e-06	1.53e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—melanoma	3.36e-06	1.51e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—melanoma	3.35e-06	1.51e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—melanoma	3.33e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—melanoma	3.32e-06	1.49e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—melanoma	3.32e-06	1.49e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—melanoma	3.3e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—melanoma	3.3e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CTNNB1—melanoma	3.3e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—melanoma	3.29e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NRAS—melanoma	3.28e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CD—melanoma	3.28e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—melanoma	3.27e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—melanoma	3.27e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CB—melanoma	3.26e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1B—melanoma	3.24e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—melanoma	3.24e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—melanoma	3.24e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—melanoma	3.23e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—melanoma	3.23e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK1—melanoma	3.23e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—melanoma	3.23e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NRAS—melanoma	3.23e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.22e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—melanoma	3.21e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.21e-06	1.44e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK1—melanoma	3.2e-06	1.44e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—melanoma	3.2e-06	1.44e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.2e-06	1.44e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCB1—melanoma	3.19e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—melanoma	3.18e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—melanoma	3.17e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—melanoma	3.16e-06	1.42e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—melanoma	3.14e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.14e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—melanoma	3.1e-06	1.39e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—melanoma	3.09e-06	1.39e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.09e-06	1.39e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CD—melanoma	3.09e-06	1.39e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—melanoma	3.08e-06	1.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.06e-06	1.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—melanoma	3.06e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—melanoma	3.05e-06	1.37e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—melanoma	3.05e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—melanoma	3.02e-06	1.36e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—melanoma	3.01e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—melanoma	3e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1A—melanoma	2.99e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK1—melanoma	2.99e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—melanoma	2.99e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—melanoma	2.99e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—melanoma	2.98e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NFKB1—melanoma	2.97e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.94e-06	1.32e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—melanoma	2.94e-06	1.32e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PRKCA—melanoma	2.93e-06	1.32e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—melanoma	2.91e-06	1.31e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—melanoma	2.91e-06	1.31e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.9e-06	1.31e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—melanoma	2.87e-06	1.29e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NRAS—melanoma	2.87e-06	1.29e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CB—melanoma	2.86e-06	1.29e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—melanoma	2.85e-06	1.28e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—melanoma	2.83e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—melanoma	2.82e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—melanoma	2.82e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.8e-06	1.26e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—melanoma	2.78e-06	1.25e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—melanoma	2.78e-06	1.25e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.75e-06	1.23e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—melanoma	2.72e-06	1.22e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—melanoma	2.71e-06	1.22e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.7e-06	1.21e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CB—melanoma	2.69e-06	1.21e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—melanoma	2.69e-06	1.21e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—melanoma	2.67e-06	1.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—melanoma	2.67e-06	1.2e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—melanoma	2.67e-06	1.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NRAS—melanoma	2.66e-06	1.2e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.61e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—melanoma	2.61e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—melanoma	2.59e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—melanoma	2.59e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—melanoma	2.57e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.55e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.55e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—melanoma	2.53e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—melanoma	2.52e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—melanoma	2.51e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—melanoma	2.51e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—melanoma	2.48e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—melanoma	2.48e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—melanoma	2.47e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—melanoma	2.47e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—melanoma	2.47e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—melanoma	2.46e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.43e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—melanoma	2.43e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—melanoma	2.4e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—melanoma	2.36e-06	1.06e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—melanoma	2.33e-06	1.05e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—melanoma	2.3e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—melanoma	2.3e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—melanoma	2.29e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—melanoma	2.29e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—melanoma	2.27e-06	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.27e-06	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—melanoma	2.26e-06	1.02e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—melanoma	2.22e-06	9.97e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—melanoma	2.19e-06	9.86e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—melanoma	2.12e-06	9.53e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.11e-06	9.47e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—melanoma	2.1e-06	9.43e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—melanoma	2.09e-06	9.38e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—melanoma	2.06e-06	9.26e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—melanoma	2.04e-06	9.16e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CD—melanoma	2.02e-06	9.08e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—melanoma	2.01e-06	9.03e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—melanoma	1.99e-06	8.97e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—melanoma	1.99e-06	8.94e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—melanoma	1.95e-06	8.76e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—melanoma	1.87e-06	8.39e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—melanoma	1.85e-06	8.33e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CB—melanoma	1.76e-06	7.92e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—melanoma	1.74e-06	7.85e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—melanoma	1.74e-06	7.83e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—melanoma	1.72e-06	7.74e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—melanoma	1.64e-06	7.38e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—melanoma	1.62e-06	7.3e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—melanoma	1.52e-06	6.84e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—melanoma	1.42e-06	6.4e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—melanoma	1.34e-06	6.03e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—melanoma	1.07e-06	4.83e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—melanoma	8.77e-07	3.94e-06	CbGpPWpGaD
